MedPath

The Effect of Premedication on Postoperative Pain and Anxiety in Breast Cancer Surgery

Recruiting
Conditions
Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery
Interventions
Registration Number
NCT05647642
Lead Sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Brief Summary

In this study, it was investigated whether the premedication drug administered before the surgery had an effect on postoperative pain and anxiety scores in female patients under the age of 65 who will undergo breast cancer surgery.

Detailed Description

In this study, it was investigated whether the premedication drug administered before the surgery had an effect on postoperative pain and anxiety scores in female patients under the age of 65 who will undergo breast cancer surgery. The STAI-1(State Trait Anxiety İnventory ) form and APAIS (Amsterdam Preoperative Anxiety and İnformation Scale) scale were filled in for all preoperative patients. Afterwards, the patients were treated with either midazolam or dexmedetothymidine, depending on the anesthesiologist's preference. After administration, he was taken to surgery. As intraoperative analgesics, 2 mg/kg tramadol and 15 mg/kg paracetamol were administered to all patients. postoperative recovery time (aldrete 10), 1., 2.,6.,12.,24. VAS score, postoperative nausea-vomiting scale, STAI-1(State Trait Anxiety İnventory ) form, first need time if postoperative analgesic was needed, and 24-hour total analgesic consumption were recorded. It was aimed to examine the effects of different premedications on postoperative pain and anxiety

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • ASA 1-2-3
  • 18-65 aged
  • Female patients
Exclusion Criteria
  • Under 18 years old and over 65 years old
  • Having a history of cerebrovascular disease illiteracy
  • Have visual and auditory problems İnability to cooperate with cognitive function test
  • Having emergency surgery
  • Those who are unable to read, understand and sign the consent form
  • Patients deemed unsuitable by the investigator

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
low dose dexmedetothymidinePrecedex and dormicum0.5 mg/kg dexmedetothymidine 10 minute infusion
low dose midazolamPrecedex and dormicum0,025 mg/kg Midazolam
high dose midazolamPrecedex and dormicum0,05 mg/kg Midazolam
high dose dexmedetothymidinePrecedex and dormicum1mg/kg dexmedetothymidine 10 minute infusion
Primary Outcome Measures
NameTimeMethod
effect of premedication on postoperative pain and anxiety scoresNovember 2022-December 2022
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

AbdurrahmanYAOTRH

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath